BIBLIOGRAFIA
- Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P.Aesthet Surg J. 2020 Jan
- Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P.Aesthet Surg J. 2020 Aug
- Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial.Ascher B, Kestemont P, Boineau D, Bodokh I, Stein A, Heckmann M, Dendorfer M, Pavicic T, Volteau M, Tse A, Picaut P, Rzany B.Aesthet Surg J. 2018 Feb
- Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study.Kestemont P, Hilton S, Andriopoulos B, Prygova I, Thompson C, Volteau M, Ascher B.Aesthet Surg J. 2022 Feb
- Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports.Torres S, Hamilton M, Sanches E, Starovatova P, Gubanova E, Reshetnikova T.Clin Cosmet Investig Dermatol. 2013 Dec
- Botulinum toxin and the facial feedback hypothesis: can looking better make you feel happier?Alam M, Barrett KC, Hodapp RM, Arndt KA.J Am Acad Dermatol. 2008 Jun
- Effects of botulinum toxin type a on mood and cognitive function in patients with parkinson’s disease and depression. Zhu C, Wang K, Yu T, Liu H.Am J Transl Res. 2021 Apr
- Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective. Li Y, Liu T, Luo W.Front Psychiatry. 2021 Apr
